These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 1665741)

  • 1. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
    Delpy E; Coste H; Gouville AC
    Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM; Kuo SC
    Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
    Lugnier C; Komas N
    Eur Heart J; 1993 Nov; 14 Suppl I():141-8. PubMed ID: 8293765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries.
    Liu SF; Crawley DE; Rohde JA; Evans TW; Barnes PJ
    Br J Pharmacol; 1992 Nov; 107(3):861-6. PubMed ID: 1335345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta.
    Lindgren S; Rascón A; Andersson KE; Manganiello V; Degerman E
    Biochem Pharmacol; 1991 Jul; 42(3):545-52. PubMed ID: 1650216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
    Eckly-Michel A; Martin V; Lugnier C
    Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors.
    Shahid M; van Amsterdam RG; de Boer J; ten Berge RE; Nicholson CD; Zaagsma J
    Br J Pharmacol; 1991 Oct; 104(2):471-7. PubMed ID: 1665737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF from endothelial cells.
    Ito M; Yamamoto I; Naruse A; Suzuki Y; Satake N; Shibata S
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):232-9. PubMed ID: 9057073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.
    Turner NC; Lamb J; Worby A; Murray KJ
    Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
    Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
    Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent and -independent effects of exogenous ATP, adenosine, GTP and guanosine on vascular tone and cyclic nucleotide accumulation of rat mesenteric artery.
    Vuorinen P; Pörsti I; Metsä-Ketelä T; Manninen V; Vapaatalo H; Laustiola KE
    Br J Pharmacol; 1992 Feb; 105(2):279-84. PubMed ID: 1313722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.
    Gray DW; Marshall I
    Br J Pharmacol; 1992 Nov; 107(3):684-90. PubMed ID: 1335334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
    Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ
    Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
    Souness JE; Hassall GA; Parrott DP
    Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
    Souness JE; Brazdil R; Diocee BK; Jordan R
    Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.